Literature DB >> 3192733

Plasma oxalate concentration and secondary oxalosis in patients with chronic renal failure.

C R Tomson1, S M Channon, I S Parkinson, A R Morley, T W Lennard, N R Parrott, M F Laker.   

Abstract

To examine the association between hyperoxalaemia and secondary oxalosis, measurement of plasma oxalate concentration was combined with a search for tissue deposition of calcium oxalate crystals in patients with chronic renal disease. Two groups of patients were studied. In the first, samples of the inferior epigastric artery were taken from 35 patients at the time of renal transplantation. In the second, sections taken at necropsy from 23 patients with chronic renal failure in whom plasma oxalate had been measured before death were examined. Though plasma oxalate concentrations ranged between 6 and 116 mumol/l (four to 78 times greater than the upper limit of the reference range), no extrarenal deposits of oxalate were found in either study. Renal deposition of oxalate was associated with a plasma oxalate concentration of greater than 20 mumol/l. This study gives no support to the suggestion that hyperoxalaemia of the degree seen in patients with the type of chronic renal failure that is not due to primary hyperoxaluria confers an appreciable risk of extrarenal oxalosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3192733      PMCID: PMC1141697          DOI: 10.1136/jcp.41.10.1107

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  18 in total

1.  [Secondary uremic oxalosis].

Authors:  B BEDNAR; A JIRASEK; J STEJSKAL; M CHYTIL
Journal:  Zentralbl Allg Pathol       Date:  1961-05-31

2.  Oxalosis as a complication of chronic renal failure.

Authors:  W R Salyer; D Keren
Journal:  Kidney Int       Date:  1973-07       Impact factor: 10.612

3.  Cardiac lesions in secondary oxalosis.

Authors:  W R Salyer; G M Hutchins
Journal:  Arch Intern Med       Date:  1974-08

4.  Oxalate nephrosis and crystalline myocarditis. Case report with postmortem and crystallographic studies.

Authors:  R D Lewis; H A Lowenstam; G R Rossman
Journal:  Arch Pathol       Date:  1974-09

5.  Terminal renal failure due to oxalosis in 14 patients.

Authors:  C Jacobs; J Rottembourgh; I Reach; M Legrain
Journal:  Proc Eur Dial Transplant Assoc       Date:  1975

6.  Oxalosis in chronic renal failure.

Authors:  C T op de Hoek; P P Diderich; S Gratama; E J Weijs- von Hofwegen
Journal:  Proc Eur Dial Transplant Assoc       Date:  1980

7.  [Oxalosis in chronic renal failure or chronic dialysis or both (author's transl)].

Authors:  K Ishida; N Yamanaka
Journal:  Nihon Hinyokika Gakkai Zasshi       Date:  1980-12

8.  The role of hypertension in hemodialysis-associated atherosclerosis.

Authors:  F Vincenti; W J Amend; J Abele; N J Feduska; O Salvatierra
Journal:  Am J Med       Date:  1980-03       Impact factor: 4.965

9.  Oxalosis in hemodialysis patients: a pathologic study of 80 cases.

Authors:  A O Fayemi; M Ali; E V Braun
Journal:  Arch Pathol Lab Med       Date:  1979-02       Impact factor: 5.534

10.  Arterial lesions of the radial artery in uraemic patients.

Authors:  S Ejerblad; J L Ericsson; I Eriksson
Journal:  Acta Chir Scand       Date:  1979
View more
  4 in total

1.  Calcium oxalate saturation in dialysis patients with and without primary hyperoxaluria.

Authors:  Yoshihide Ogawa; Noriko Machida; Tomohide Ogawa; Masami Oda; Sanehiro Hokama; Yoshiaki Chinen; Atsushi Uchida; Makoto Morozumi; Kimio Sugaya; Yaeko Motoyoshi; Motofumi Hattori
Journal:  Urol Res       Date:  2006-01-24

2.  Primary hyperoxaluria--a case report.

Authors:  F Brett; W F Kealy; D Murnaghan; J M Hogan
Journal:  Ir J Med Sci       Date:  1990-03       Impact factor: 1.568

3.  Pathophysiology and Treatment of Enteric Hyperoxaluria.

Authors:  Celeste Witting; Craig B Langman; Dean Assimos; Michelle A Baum; Annamaria Kausz; Dawn Milliner; Greg Tasian; Elaine Worcester; Meaghan Allain; Melissa West; Felix Knauf; John C Lieske
Journal:  Clin J Am Soc Nephrol       Date:  2020-09-08       Impact factor: 8.237

4.  Vitamin C deficiency and impact of vitamin C administration among pediatric patients with advanced chronic kidney disease.

Authors:  Nattaphorn Hongsawong; Notethasoung Chawprang; Kulnipa Kittisakmontri; Parach Vittayananan; Konggrapun Srisuwan; Wattana Chartapisak
Journal:  Pediatr Nephrol       Date:  2020-07-19       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.